[Chinese expert recommendations on the standardized establishment of hemoptysis centers].

Hemoptysis is a common and challenging clinical emergency, frequently secondary to high-prevalence diseases in China-such as pulmonary tuberculosis, bronchiectasis, lung cancer, and pulmonary mycosis-as well as respiratory interventional procedures. Patients with life-threatening massive hemoptysis can succumb to asphyxia or hemorrhagic shock within minutes. Currently, clinical practices in hemoptysis management across China exhibit significant disparities among different regions and hospital tiers, characterized by an overall deficit in rescue capabilities and high rates of mortality and disability. The establishment of hemoptysis centers, drawing on the experience of chest pain centers and stroke centers, has become imperative. Several hospitals across various provinces and municipalities in China have already established Hemoptysis Centers, yielding favorable clinical outcomes, and an increasing number of hospitals nationwide are actively advancing the development of these centers. To ensure the standardized and orderly establishment of these centers, the Chinese Thoracic Society, the Chinese Antituberculosis Association, the Interventional Pulmonology Group of the Chinese Association of Chest Physicians, and the Hemoptysis Expert Committee of the Haemorrhage Professional Committee of the Chinese Research Hospital Association convened national experts in related fields to formulate these Expert Recommendations on the standardized established of hemoptysis centers. As the first consensus of their kind both domestically and internationally, these recommendations aim to standardize the establishment of Hemoptysis Centers, promote the development of a nationwide Hemoptysis Center network, improve the success rate of hemoptysis treatment, and reduce the mortality and disability rates of affected patients.